Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension

NCT01409031 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01409031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01409031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2011
Completion date
October 31, 2013
Enrollment
3 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

persistent pulmonary hypertension, respiratory failure